Publication Cover
Child Neuropsychology
A Journal on Normal and Abnormal Development in Childhood and Adolescence
Volume 21, 2015 - Issue 5
1,751
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Prenatal SSRI exposure: Effects on later child development

&
Pages 543-569 | Received 04 Mar 2014, Accepted 03 Jul 2014, Published online: 04 Aug 2014

REFERENCES

  • Andersen, S. L. (2003). Trajectories of brain development: Point of vulnerability or window of opportunity? Neuroscience and Biobehavioral Reviews, 27(1–2), 3–18. doi:10.1016/s0149-7634(03)00005-8
  • Anderson, P. (2002). Assessment and development of executive function (EF) during childhood. Child Neuropsychology (Neuropsychology, Development and Cognition: Section C), 8(2), 71–82. doi:10.1076/chin.8.2.71.8724
  • Andrews, M. H., & Matthews, S. G. (2004). Programming of the hypothalamo–pituitary–adrenal axis: Serotonergic involvement. Stress: The International Journal on the Biology of Stress, 7(1), 15–27. doi:10.1080/10253890310001650277
  • Arnsten, A. F. T. (2000). Genetics of childhood disorders: XVIII. ADHD, Part 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. Journal of the American Academy of Child and Adolescent Psychiatry, 39(9), 1201–1203. doi:10.1097/00004583-200009000-00022
  • Ashman, S. B., Dawson, G., & Panagiotides, H. (2008). Trajectories of maternal depression over 7 years: Relations with child psychophysiology and behavior and role of contextual risks. Development and Psychopathology, 20(1), 55–77. doi:10.1017/S0954579408000035
  • Azak, S., Murison, R., Wentzel-Larsen, T., Smith, L., & Gunnar, M. R. (2013). Maternal depression and infant daytime cortisol. Developmental Psychobiology, 55(4), 334–351. doi:10.1002/dev.21033
  • Barnes, N. M., & Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmachology, 38(8), 1083–1152. doi:10.1016/S0028-3908(99)00010-6
  • Bayley, N. (2005). Bayley scales of infant and toddler development (3rd ed.). San Antonio, TX: The Psychologcial Corporation.
  • Belsky, J., & Pluess, M. (2009). Beyond diathesis stress: Differential susceptibility to environmental influences. Psychological Bulletin, 135(6), 885–908. doi:10.1037/a0017376
  • Bhattacharyya, A., Oppenheim, R. W., Prevette, D., Moore, B. W., Brackenbury, R., & Ratner, N. (1992). S100 is present in developing chicken neurons and schwann cell and promotes motor neuron survivalin vivo. Journal of Neurobiology, 23(4), 451–466. doi:10.1002/neu.480230410
  • Bhutta, A. T., Cleves, M. A., Casey, P. H., Cradock, M. M., & Anand, K. J. S. (2002). Cognitive and behavioral outcomes of school-aged children who were born preterm - A Meta-Analysis. Jama-Journal of the American Medical Association, 288(6), 728–737. doi:10.1001/jama.288.6.728
  • Biringer, E., Rongve, A., & Lund, A. (2009). A review of modern antidepressants’ effects on neurocognitive function. Current Psychiatry Reviews, 5(3), 164–174. doi:10.2174/157340009788971137
  • Bishop, S. R., Lau, M., Shapiro, S., Carlson, L., Anderson, N. D., Carmody, J., … Devins, G. (2004). Mindfulness: A proposed operational definition. Clinical Psychology: Science and Practice, 11(3), 230–241. doi:10.1093/clipsy.bph077
  • Blair, C., Granger, D., & Razza, R. P. (2005). Cortisol reactivity is positively related to executive function in preschool children attending head start. Child Development, 76(3), 554–567. doi:10.1111/j.1467-8624.2005.00863.x
  • Boulet, S. L., Schieve, L. A., & Boyle, C. A. (2011). Birth weight and health and developmental outcomes in US children, 1997–2005. Maternal and Child Health Journal, 15(7), 836–844. doi:10.1007/s10995-009-0538-2
  • Brambilla, P., Cipriani, A., Hotopf, M., & Barbui, C. (2005). Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: A meta-analysis of clinical trial data. Pharmacopsychiatry, 38, 69–77. doi:10.1055/s-2005-837806
  • Branchi, I. (2011). The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology, 36(3), 339–351. doi:10.1016/j.psyneuen.2010.08.011
  • Branchi, I., Francia, N., & Alleva, E. (2004). Epigenetic control of neurobehavioural plasticity: The role of neurotrophins. Behavioural Pharmacology, 15(5), 353–362. doi:10.1097/00008877-200409000-00006
  • Buitelaar, J. K., Huizink, A. C., Mulder, E. J., de Medina, P. G. R., & Visser, G. H. A. (2003). Prenatal stress and cognitive development and temperament in infants. Neurobiology of Aging, 24, SS53–SS60. doi:10.1016/s0197-4580(03)00050-2
  • Casper, R. C., Fleisher, B. E., Lee-Ancajas, J. C., Gilles, A., Gaylor, E., DeBattista, A., & Hoyme, H. E. (2003). Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. The Journal of Pediatrics, 142, 402–408. doi:10.1067/mpd.2003.139
  • Casper, R. C., Gilles, A. A., Fleisher, B. E., Baran, J., Enns, G., & Lazzeroni, L. C. (2011). Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: Effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl), 217(2), 211–219. doi:10.1007/s00213-011-2270-z
  • Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., … Poulton, R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386–389. doi:10.1126/science.1083968
  • Chambers, C. D., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996). Birth outcomes in pregnant women taking fluoxetine. The New England Journal of Medicine, 335(14), 1010–1015. doi:10.1056/NEJM199610033351402
  • Cohen, J. (1992). Statistical power analysis. Current Directions in Psychological Science, 1(3), 98–101. doi:10.1111/1467-8721.ep10768783
  • Cohn, J. F., & Tronick, E. (1989). Specificity of infants’ response to mothers’ affective behavior. Journal of the American Academy of Child and Adolescent Psychiatry, 28(2), 242–248. doi:10.1097/00004583-198903000-00016
  • Cools, R., Roberts, A. C., & Robbins, T. W. (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends in Cognitive Sciences, 12(1), 31–40. doi:10.1016/j.tics.2007.10.011
  • Cuijpers, P., Geraedts, A. S., van Oppen, P., Andersson, G., Markowitz, J. C., & van Straten, A. (2011). Interpersonal psychotherapy for depression: A meta-analysis. American Journal of Psychiatry, 168(6), 581–592. doi:10.1176/appi.ajp.2010.10101411
  • Dailly, E., Chenu, F., Renard, C. E., & Bourin, M. (2004). Dopamine, depression and antidepressants. Fundamental & Clinical Pharmacology, 18(6), 601–607. doi:10.1111/j.1472-8206.2004.00287.x
  • Davidson, M. C., Amso, D., Anderson, L. C., & Diamond, A. (2006). Development of cognitive control and executive functions from 4 to 13 years: Evidence from manipulations of memory, inhibition, and task switching. Neuropsychologia, 44(11), 2037–2078. doi:10.1016/j.neuropsychologia.2006.02.006
  • Davis, E. P., & Sandman, C. A. (2010). The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Development, 81(1), 131–148. doi:10.1111/j.1467-8624.2009.01385.x
  • de Kloet, E. R., Joëls, M., & Holsboer, F. (2005). Stress and the brain: From adaptation to disease. Nature Reviews Neuroscience, 6(6), 463–475. doi:10.1038/nrn1683
  • Deave, T., Heron, J., Evans, J., & Emond, A. (2008). The impact of maternal depression in pregnancy on early child development. \BJOG: An International Journal of Obstetrics & Gynaecology, 115(8), 1043–1051. doi:10.1111/j.1471-0528.2008.01752.x
  • Devlin, A. M., Brain, U., Austin, J., & Oberlander, T. F. (2010). Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. Plos One, 5(8), e12201–e12209. doi:10.1371/journal.pone.0012201
  • Diego, M. A., Field, T., Jones, N. A., Hernandez-Reif, M., Cullen, C., Schanberg, S., & Kuhn, C. (2004). EEG responses to mock facial expressions by infants of depressed mothers. Infant Behavior and Development, 27(2), 150–162. doi:10.1016/j.infbeh.2003.10.001
  • dos Santos, E. S. L., de Kieviet, J. F., Königs, M., van Elburg, R. M., & Oosterlaan, J. (2013). Predictive value of the Bayley scales of infant development on development of very preterm/very low birth weight children: A meta-analysis. Early Human Development, 89(7), 487–496. doi:10.1016/j.earlhumdev.2013.03.008
  • Einarson, T. R., & Einarson, A. (2005). Newer antidepressants in pregnancy and rates of major malformations: A meta-analysis of prospective comparative studies. Pharmacoepidemiology and Drug Safety, 14(12), 823–827. doi:10.1002/pds.1084
  • El Marroun, H., Jaddoe, V. W. V., Hudziak, J. J., Roza, S. J., Steegers, E. A. P., Hofman, A., … Tiemeier, H. (2012). Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Archives of General Psychiatry, 69(7), 706–714. doi:10.1001/archgenpsychiatry.2011.2333
  • Evans, J., Melotti, R., Heron, J., Ramchandani, P., Wiles, N., Murray, L., & Stein, A. (2012). The timing of maternal depressive symptoms and child cognitive development: A longitudinal study. Journal of Child Psychology and Psychiatry, 53(6), 632–640. doi:10.1111/j.1469-7610.2011.02513.x
  • Evers, E. A. T., van der Veen, F. M., Fekkes, D., & Jolles, J. (2007). Serotonin and cognitive flexibility: Neuroimaging studies into the effect of acute tryptophan depletion in healthy volunteers. Current Medicinal Chemistry, 14(28), 2989–2995. doi:10.2174/092986707782794032
  • Fattal-Valevski, A., Leitner, Y., Geva, R., Bassan, H., Goez, H., Jaffa, A. J., & Harel, S. (2001). The effect of intrauterine growth restriction on the development and health of children. Nutrition and Health (Bicester), 15(3–4), 169–175. doi:10.1177/026010600101500404
  • Fernández-Pastor, B., Ortega, J. E., & Meana, J. J. (2013). Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: A microdialysis study in rat brain. Psychopharmacology, 229, 331–344. doi:10.1007/s00213-013-3112-y
  • Field, T., Diego, M., Dieter, J., Hernandez Reif, M., Schanberg, S., Kuhn, C., … Bendell, D. (2004). Prenatal depression effects on the fetus and the newborn. Infant Behavior and Development, 27(2), 216–229. doi:10.1016/j.infbeh.2003.09.010
  • Field, T., Diego, M., Hernandez-Reif, M., Vera, Y., Gil, K., Schanberg, … Gonzalez-Garcia, A. (2004). Prenatal maternal biochemistry predicts neonatal biochemistry. International Journal of Neuroscience, 114(8), 933–945. doi:10.1080/00207450490461305
  • Field, T. M. (1984). Early interactions between infants and their postpartum depressed mothers. Infant Behavior and Development, 7(4), 517–522. doi:10.1016/s0163-6383(84)80010-7
  • Fikke, L. T., Melinder, A., & Landrø, N. I. (2013). The effects of acute tryptophan depletion on impulsivity and mood in adolescents engaging in non-suicidal self-injury. Human Psychopharmacology: Clinical and Experimental, 28(1), 61–71. doi:10.1002/hup.2283
  • Fitzgerald, P. J. (2011). A neurochemical yin and yang: Does serotonin activate and norepinephrine deactivate the prefrontal cortex? Psychopharmacology, 213, 171–182. doi:10.1007/s00213-010-1856-1
  • Fjorback, L. O., Arendt, M., Ørnbøl, E., Fink, P., & Walach, H. (2011). Mindfulness-based stress reduction and mindfulness-based cognitive therapy - A systematic review of randomized controlled trials. Acta Psychiatrica Scandinavica, 124(2), 102–119. doi:10.1111/j.1600-0447.2011.01704.x
  • Galbally, M., Lewis, A. J., & Buist, A. (2011). Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry, 45(5), 393–399. doi:10.3109/00048674.2010.549995
  • Gaspar, P., Cases, O., & Maroteaux, L. (2003). The developmental role of serotonin: News from mouse molecular genetics. Nature Reviews Neuroscience, 4(12), 1002–1012. doi:10.1038/nrn1256
  • Gentile, S. (2010). Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety, 27(7), 675–686. doi:10.1002/da.20706
  • Gentile, S., Rossi, A., & Bellantuono, C. (2007). SSRIs during breastfeeding: Spotlight on milk-to-plasma ratio. Archives of Womens Mental Health, 10(2), 39–51. doi:10.1007/s00737-007-0173-0
  • Ghodsian, M., Zajicek, E., & Wolkind, S. (1984). A longitudinal study of maternal depression and child behaviour problems. Journal of Child Psychology and Psychiatry and Allied Disciplines, 25(1), 91–109. doi:10.1111/j.1469-7610.1984.tb01721.x
  • Gonzalez-Martinez, T., Perez-Pinera, P., Diaz-Esnal, B., & Vega, J. A. (2003). S-100 proteins in the human peripheral nervous system. Microscopy Research and Technique, 60(6), 633–638. doi:10.1002/jemt.10304
  • Gunnar, M. R., & Fisher, P. A. (2006). Bringing basic research on early experience and stress neurobiology to bear on preventive interventions for neglected and maltreated children. Development and Psychopathology, 18(3), 651–677. doi:10.1017/s0954579406060330
  • Hanley, G. E., Brain, U., & Oberlander, T. F. (2013). Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Human Development, 89(8), 519–524. doi:10.1016/j.earlhumdev.2012.12.012
  • Hayden, E. P., Hanna, B., Sheikh, H. I., Laptook, R. S., Kim, J., Singh, S. M., & Klein, D. N. (2013). Child dopamine active transporter 1 genotype and parenting: Evidence for evocative gene-environment correlations. Development and Psychopathology, 25(1), 163–173. doi:10.1017/S0954579412000971
  • Hayes, L. J., Goodman, S. H., & Carlson, E. (2013). Maternal antenatal depression and infant disorganized attachment at 12 months. Attachment & Human Development, 15(2), 133–153. doi:10.1080/14616734.2013.743256
  • Hendrick, V., Stowe, Z. N., Altshuler, L. L., Hwang, S., Lee, E., & Haynes, D. (2003). Placental passage of antidepressant medications. American Journal of Psychiatry, 160(5), 993–996. doi:10.1176/appi.ajp.160.5.993
  • Herlenius, E., & Lagercrantz, H. (2004). Development of neurotransmitter systems during critical periods. Experimental Neurology, 190, 8–21. doi:10.1016/j.expneurol.2004.03.027
  • Hoenig, J. M., & Heisey, D. M. (2001). The abuse of power: The pervasive fallacy of power calculations for data analysis. The American Statistician, 55(1), 19–24. doi:10.1198/000313001300339897
  • Homberg, J. R., & Lesch, K. P. (2011). Looking on the bright side of serotonin transporter gene variation. Biological Psychiatry, 69, 513–519. doi:10.1016/j.biopsych.2010.09.024
  • Homberg, J. R., Schubert, D., & Gaspar, P. (2010). New perspectives on the neurodevelopmental effects of SSRIs. Trends in Pharmacological Sciences, 31(2), 60–65. doi:10.1016/j.tips.2009.11.003
  • Howell, D. C. (2007). Statistical methods for psychology (8th ed.). Boston, MA: Wadsworth, Cengage Learning.
  • Huizink, A. C., de Medina, P. G. R., Mulder, E. J. H., Visser, G. H. A., & Buitelaar, J. K. (2003). Stress during pregnancy is associated with developmental outcome in infancy. Journal of Child Psychology and Psychiatry and Allied Disciplines, 44(6), 810–818. doi:10.1111/1469-7610.00166
  • Huybrechts, K. F., Palmsten, K., Mogun, H., Kowal, M., Avorn, J., Setoguchi-Iwata, S., & Hernández-Díaz, S. (2013). National trends in antidepressant medication treatment among publicly insured pregnant women. General Hospital Psychiatry, 35(3), 265–271. doi:10.1016/j.genhosppsych.2012.12.010
  • Iqbal, M., Audette, M. C., Petropoulos, S., Gibb, W., & Matthews, S. G. (2012). Placental drug transporters and their role in fetal protection. Placenta, 33(3), 137–142. doi:10.1016/j.placenta.2012.01.008
  • Isbister, G. K., Dawson, A., Whyte, I. M., Prior, F. H., Clancy, C., & Smith, A. J. (2001). Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Archives of Disease in Childhood, 85(2), F147–F148. Retrieved from http://fn.bmj.com/content/85/2/F145.7.full
  • Jacobs, B. L., & Fornal, C. A. (1997). Serotonin and motor activity. Current Opinion in Neurobiology, 7(6), 820–825. doi:10.1016/s0959-4388(97)80141-9
  • Karlsson, S., Rieckmann, A., Karlsson, P., Farde, L., Nyberg, L., & Bäckman, L. (2011). Relationship of dopamine D1 receptor binding in striatal and extrastriatal regions to cognitive functioning in healthy humans. NeuroImage, 57(2), 346–351. doi:10.1016/j.neuroimage.2011.04.047
  • Karpova, N. N., Lindholm, J., Pruunsild, P., Timmusk, T., & Castrén, E. (2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. European Neuropsychopharmacology, 19(2), 97–108. doi:10.1016/j.euroneuro.2008.09.002
  • Kieler, H., Artam, M., Engeland, A., Ericsson, Ol., Furu, K., Gissler, M., … Haglund, B. (2012). Selective Serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. British Medical Journal, 344, 1–9. doi:10.1136/bmj.d8012
  • Kiser, D., SteemerS, B., Branchi, I., & Homberg, J. R. (2012). The reciprocal interaction between serotonin and social behaviour. Neuroscience and Biobehavioral Reviews, 36(2), 786–798. doi:10.1016/j.neubiorev.2011.12.009
  • Klimek, V., & Nielsen, M. (1987). Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. European Journal of Pharmacology, 139(2), 163–169. doi:10.1016/0014-2999(87)90248-2
  • Klinger, G., Frankenthal, D., Merlob, P., Diamond, G., Sirota, L., Levinson-Castiel, R., Linder, N., Stahl, B., & Inbar, D. (2011). Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Journal of Perinatology, 31(9), 615–620. doi:10.1038/jp.2010.211
  • Klinger, G., & Merlob, P. (2008). Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Israel Journal of Psychiatry and Related Sciences, 45(2), 107–113. Retrieved from http://acupuncture.doctorsonly.co.il/wp-content/uploads/2011/12/2008_2_7.pdf
  • Konijnenberg, C., & Melinder, A. (2013). Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy. Addiction, 108(1), 154–160. doi:10.1111/j.1360-0443.2012.04006.x
  • Koutra, K., Chatzi, L., Bagkeris, M., Vassilaki, M., Bitsios, P., & Kogevinas, M. (2013). Antenatal and postnatal maternal mental health as determinants of infant neurodevelopment at 18 months of age in a mother-child cohort (Rhea Study) in Crete, Greece. Social Psychiatry and Psychiatric Epidemiology, 48(8), 1335–1345. doi:10.1007/s00127-012-0636-0
  • Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003). Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Archives of General Psychiatry, 60(7), 720–726. doi:10.1001/archpsyc.60.7.720
  • Lampe, L., Coulston, C. M., & Berk, L. (2013). Psychological management of unipolar depression. Acta Psychiatrica Scandinavica, 127, 24–37. doi:10.1111/acps.12123
  • Lenth, R. V. (2001). Some practical guidelines for effective sample size determination. The American Statistician, 55(3), 187–193. doi:10.1198/000313001317098149
  • Lenth, R. V. (2006–2009). Java Applets for Power and Sample Size [Computer software]. Retrieved from http://www.stat.uiowa.edu/~rlenth/Power
  • Lesch, K.-P. (2007). Linking emotion to the social brain - The role of the serotonin transporter in human social behaviour. Embo Reports, 8, SS24–SS29. doi:10.1038/sj.embor.7401008
  • Lundy, B. L. (2002). Paternal socio-psychological factors and infant attachment: The mediating role of synchrony in father-infant interactions. Infant Behavior and Development, 25(2), 221–236. doi:10.1016/s0163-6383(02)00123-6
  • Lundy, B. L., Jones, N. A., Field, T., Nearing, G., Davalos, M., Pietro, P. A., … Kuhn, C. (1999). Prenatal depression effects on neonates. Infant Behavior and Development, 22(1), 119–129. doi:10.1016/s0163-6383(99)80009-5
  • Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience, 10(6), 434–445. doi:10.1038/nrn2639
  • Marcovitch, S., Goldberg, S., Gold, A., Washington, J., Wasson, C., Krekewich, K., & HandleyDerry, M. (1997). Determinants of behavioural problems in Romanian children adopted in Ontario. International Journal of Behavioral Development, 20(1), 17–31. doi:10.1080/016502597385414
  • Martins, C., & Gaffan, E. A. (2000). Effects of early maternal depression on patterns of infant-mother attachment: A meta-analytic investigation. Journal of Child Psychology and Psychiatry and Allied Disciplines, 41(6), 737–746. doi:10.1111/1469-7610.00661
  • McCarthy, D. (1972). The McCarthy scales of children’s abilities. New York, NY: The Psychological Corporation.
  • Meier, E., Hertz, L., & Schousboe, A. (1991). Neurotransmitters as developmental signals. Neurochemistry International, 19(1–2), 1–15. doi:10.1016/0197-0186(91)90113-r
  • Melinder, A., Forbes, D., Tronick, E., Fikke, L., & Gredebäck, G. (2010). The development of the still-face effect: Mothers do matter. Infant Behavior and Development, 33(4), 472–481. doi:10.1016/j.infbeh.2010.05.003
  • Melinder, A., Konijnenberg, C., & Sarfi, M. (2013). Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities. Addiction, 108, 2175–2182. doi:10.1111/add.12267
  • Mendelsohn, D., Riedel, W. J., & Sambeth, A. (2009). Effects of acute tryptophan depletion on memory, attention and executive functions: A systematic review. Neuroscience and Biobehavioral Reviews, 33(6), 926–952. doi:10.1016/j.neubiorev.2009.03.006
  • Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004). MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. Journal of Molecular Neuroscience, 24(2), 207–216. doi:10.1385/jmn:24:2:207
  • Mesman, J., van Ijzendoorn, M. H., & Bakermans-Kranenburg, M. J. (2009). The many faces of the Still-Face Paradigm: A review and meta-analysis. Developmental Review, 29(2), 120–162. doi:10.1016/j.dr.2009.02.001
  • Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan, D., Grunau, R. E., & Oberlander, T. F. (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. American Journal of Psychiatry, 163(6), 1026–1032. doi:10.1176/appi.ajp.163.6.1026
  • Monk, C. S., Spicer, J., & Champagne, F. A. (2012). Linking prenatal maternal adversity to developmental outcomes in infants: The role of epigenetic pathways. Development and Psychopathology, 24, 1361–1376. doi:10.1017/S0954579412000764
  • Morelli, E., Moore, H., Rebello, T. J., Gray, N., Steele, K., Esposito, E., … Ansorge, M. S. (2011). Chronic 5-Ht transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. Journal of Neuroscience, 31(44), 15742–15750. doi:10.1523/jneurosci.2989-11.2011
  • Moret, C., & Briley, M. (2011). The importance of norepinephrine in depression. Neurpsychiatric Disease and Treatment, 7(1), 9–13. doi:10.2147/NDT.S19619
  • Mueller, A., Brocke, B., Fries, E., Lesch, K.-P., & Kirschbaum, C. (2010). The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology, 35(2), 289–296. doi:10.1016/j.psyneuen.2009.07.002
  • Murray, L., Hipwell, A., & Hooper, R., Stein, A., Cooper, P. (1996). The cognitive development of 5-year-old children of postnatally depressed mothers. Journal of Child Psychology and Psychiatry and Allied Disciplines, 37(8), 927–935. doi:10.1111/j.1469-7610.1996.tb01490.x
  • Nordeng, H., Lindemann, R., Perminov, K. V., & Reikvam, A. (2001). Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatrica, 90(3), 288–291. doi:10.1080/080352501300067596
  • Nordeng, H., van Gelder, M. M., Spigset, O., Koren, G., Einarson, A., & Eberhard-Gran, M. (2012). Pregnancy outcome after exposure to antidepressants and the role of maternal depression: Results from the Norwegian Mother and Child Cohort Study. Journal of Clinical Psychopharmacology, 32(2), 186–194. doi:10.1097/JCP.0b013e3182490eaf
  • Nulman, I., & Koren, G. (1996). The safety of fluoxetine during pregnancy and lactation. Teratology, 53, 304–308. doi:10.1002/(SICI)1096-9926(199605)53:5<304::AID-TERA4>3.0.CO;2-0
  • Nulman, I., Koren, G., Rovet, J., Barrera, M., Pulver, A., Streiner, D., & Feldman, B. (2012). Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. The American Journal of Psychiatry, 169(11), 1165–1174. doi:10.1176/appi.ajp.2012.11111721
  • Nulman, I., Rovet, J., Stewart, D. E., & Wolpin, J. (1997). Neurodevelopment of children exposed in utero to antidepressant drugs. The New England Journal of Medicine, 336, 258–262. doi:10.1056/NEJM199701233360404
  • Nulman, I., Rovet, J., Stewart, D., Kulin, N. A., & Koren, G. (1996). Neurodevelopment of children exposed to fluoxetine (FL) in utero: A prospective longitudinal study. Clinical Pharmacology and Therapeutics, 59(2), 159–159. doi:10.1038/sj.clpt.1996.134
  • Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002). Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study. American Journal of Psychiatry, 159(11), 1889–1895. doi:10.1176/appi.ajp.159.11.1889
  • Oberlander, T. F. (2012). Fetal serotonin signaling: Setting pathways for early childhood development and behavior. Journal of Adolescent Health, 51(2), SS9–SS16. doi:10.1016/j.jadohealth.2012.04.009
  • Oberlander, T. F., Grunau, R. E., Fitzgerald, C., Papsdorf, M., Rurak, D., & Riggs, W. (2005). Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics, 115(2), 411–425. doi:10.1542/peds.2004-0420
  • Oberlander, T. F., Misri, S., Fitzgerald, C. E., Kostaras, X., Rurak, D., & Riggs, W. (2004). Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. The Journal of clinical psychiatry, 65(2), 230–237. doi:10.4088/JCP.v65n0214
  • Oberlander, T. F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., & Grunau, R. E. (2007). Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Archives of Pediatrics & Adolescent Medicine, 161(1), 22–29. doi:10.1001/archpedi.161.1.22
  • Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006). Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry, 63(8), 898–906. doi:10.1001/archpsyc.63.8.898
  • Oved, K., Morag, A., Pasmanik-Chor, M., Rehavi, M., Shomron, N., & Gurwitz, D. (2013). Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Translational Psychiatry, 3, e313–e319. doi:10.1038/tp.2013.86
  • Pawluski, J. L., Galea, L. A. M., Brain, U., Papsdorf, M., & Oberlander, T. F. (2009). Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics, 124(4), e662–670. doi:10.1542/peds.2009-0442
  • Pedersen, L. H., Henriksen, T. B., Bech, B. H., Licht, R. W., Kjaer, D., & Olsen, J. (2013). Prenatal antidepressant exposure and behavioral problems in early childhood - a cohort study. Acta Psychiatrica Scandinavica, 127(2), 126–135. doi:10.1111/acps.12032
  • Pedersen, L. H., Henriksen, T. B., & Olsen, J. (2010). Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics, 125(3), e600–608. doi:10.1542/peds.2008-3655
  • Pluess, M., Velders, F. P., Belsky, J., van Ijzendoorn, M. H., Bakermans-Kranenburg, M. J., Jaddoe, V. W. V., … Tiemeier, H. (2011). Serotonin transporter polymorphism moderates effects of prenatal maternal anxiety on infant negative emotionality. Biological Psychiatry, 69(6), 520–525. doi:10.1016/j.biopsych.2010.10.006
  • Rampono, J., Proud, S., Hackett, L. P., Kristensen, J. H., & Ilett, K. F. (2004). A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. The International Journal of Neuropsychopharmacology, 7(3), 329–334. doi:10.1017/s1461145704004286
  • Rampono, J., Simmer, K., Ilett, K., Hackett, L., Doherty, D., Elliot, R., … Forman, T. (2009). Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry, 42(3), 95–100. doi:10.1055/s-0028-1103296
  • Reebye, P. N., Morison, S. J., Panikkar, H., Misri, S., & Grunau, R. E. (2002). Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads. Infant Mental Health Journal, 23(4), 403–416. doi:10.1002/imhj.10025
  • Sameroff, A. J. (1975). Early influences on development: Fact or fancy? Merill-Palmer Quarterly-Journal of Developmental Psychology, 21(4), 267–294. Retrieved from http://www.jstor.org/stable/pdfplus/23083878.pdf?acceptTC=true&jpdConfirm=true
  • Sameroff, A. J. (Ed.). (2009). The transactional model of development: How children and contexts shape each other. Washington, DC: American Psychological Association.
  • Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005). Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis. Lancet, 365(9458), 482–487. doi:10.1016/S0140-6736(05)17865-9
  • Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1986). Glucocorticoid toxicity in the Hippocampus – Reversal by supplementation with brain fuels. Endocrine Reviews, 7(3), 284–301. doi:10.1210/edrv-7-3-284
  • Sarfi, M., Martinsen, H., Bakstad, B., Roislien, J., & Waal, H. (2009). Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine. Early Human Development, 85(12), 773–778. doi:10.1016/j.earlhumdev.2009.10.006
  • Sarfi, M., Smith, L., Waal, H., & Sundet, J. M. (2011). Risks and realities: Dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment. Infant Behavior and Development, 34(4), 578–589. doi:10.1016/j.infbeh.2011.06.006
  • Seckl, J. R. (2007). Glucocorticoids, developmental “programming” and the risk of affective dysfunction. Progress in Brain Research, 167, 17–34. doi:10.1016/S0079-6123(07)67002-2
  • Selinfreund, R. H., Barger, S. W., Pledger, W. J., & Vaneldik, L. J. (1991). Neurotrophic protein S100-Beta stimulates glial-cell proliferation. Proceedings of the National Academy of Sciences of the United States of America, 88(9), 3554–3558. doi:10.1073/pnas.88.9.3554
  • Simpson, K. L., Weaver, K. J., de Villers-Sidani, E., Cai, Z., Pang, Y., Rodriguez-Porcel, … Lin, R. C. S. (2011). Perinatal antidepressant exposure alters cortical network function in rodents. Proceedings of the National Academy of Sciences of the United States of America, 108(45), 18465–18470. doi:10.1073/pnas.1109353108
  • Sonuga-Barke, E. J., Oades, R. D., Psychogiou, L., Chen, W., Franke, B., Buitelaar, J., … Faraone, S. V. (2009). Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: The case of conduct and emotional problems in attention deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry, 50(9), 1052–1063. doi:10.1111/j.1469-7610.2009.02095.x
  • Sternbach, H. (1991). The serotonin syndrome. American Journal of Psychiatry, 148(6), 705–713. Retrieved from http://journals.psychiatryonline.org/data/Journals/AJP/3556/705.pdf
  • Sun, M., Kingdom, J., Baczyk, D., Lye, S. J., Matthews, S. G., & Gibb, W. (2006). Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta, 27(6–7), 602–609. doi:10.1016/j.placenta.2005.05.007
  • Syme, M. R., Paxton, J. W., & Keelan, J. A. (2004). Drug transfer and metabolism by the human placenta. Clinical Pharmacokinetics, 43(8), 487–514. doi:10.2165/00003088-200443080-00001
  • Takashi, H., Kato, M., Takano, H., Arakawa, R., Okumura, M., Otsuka, T., … & Suhara, T. (2008). Differential contributions of prefrontal and hippocampal dopamine D1 and D2 receptors in human cognitive functions. Journal of Neuroscience, 28(46), 12032–12038. doi:10.1523/JNEUROSCI.3446-08.2008
  • Taylor, H. G., Minich, N., Bangert, B., Filpek, P. A., & Hack, M. (2004). Long-term neuropsychological outcomes of very low birth weight: Associations with early risks for periventricular brain insults. Journal of the International Neuropsychological Society, 10(7), 987–1004. doi:10.1017/s1355617704107078
  • Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68(4), 615–623. doi:10.1037/0022-006X.68.4.615
  • Tronick, E., & Reck, C. (2009). Infants of depressed mothers. Harvard Review of Psychiatry, 17(2), 147–156. doi:10.1080/10673220902899714
  • Troutman, B. R., & Momany, A. M. (2012). Use of selective serotonin reuptake inhibitors during pregnancy and disorganised infant–mother attachment. Journal of Reproductive and Infant Psychology, 30(3), 261–277. doi:10.1080/02646838.2012.717263
  • Van Batenburg-Eddes, T., Brion, M. J., Henrichs, J., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., … Tiemeier, H. (2013). Parental depressive and anxiety symptoms during pregnancy and attention problems in children: A cross-cohort consistency study. Journal of Child Psychology and Psychiatry, 54(5), 591–600. doi:10.1111/jcpp.12023
  • Volkow, N. D., Gur, R. C., Wang, G.-J., Fowler, J. S., Moberg, P. J., Ding, Y.-S., … Logan, J. (1998). Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. The American Journal of Psychiatry, 155(3), 344–349. Retrieved from http://journals.psychiatryonline.org/article.aspx?articleid=172737
  • Weaver, K. J., Paul, I. A., Lin, R. C. S., & Simpson, K. L. (2010). Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: Dose-dependent effects. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, 293(11), 1920–1932. doi:10.1002/ar.21245
  • Wechsler, D. (2002). Wechsler Primary and Preschool Scale of Intelligence, 3rd ed (WPPSI-III). San Antonio, TX: Harcourt Assessment.
  • Wechsler, D. (2004). The Wechsler intelligence scale for children (WISC-IV Integrated) (4th ed.). London: Pearson Assessment.
  • Weinstock, M. (1997). Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis? Neuroscience and Biobehavioral Reviews, 21(1), 1–10. doi:10.1016/s0149-7634(96)00014-0
  • Williams, S. K., Lauder, J. M., & Johns, J. M. (2011). Prenatal cocaine disrupts serotonin signaling-dependent behaviors: Implications for sex differences, early stress and prenatal SSRI exposure. Current Neuropharmacology, 9(3), 478–511. doi:10.2174/157015911796557957
  • Wu, C. K., Chen, K. C., Chen, P. S., Chiu, N. T., Yeh, T. L., Lee, I. H., & Yang, Y. K. (2013). No changes in striatal dopamine transporter in antidepressant-treated patients with major depression. International Clinical Psychopharmacology, 28(3), 141–144. doi:10.1097/YIC.0b013e32835ebcd7
  • Zimmermann, P., Mohr, C., & Spangler, G. (2009). Genetic and attachment influences on adolescents’ regulation of autonomy and aggressiveness. Journal of Child Psychology and Psychiatry, 50(11), 1339–1347. doi:10.1111/j.1469-7610.2009.02158.x
  • Zusso, M., Debetto, P., Guidolin, D., Barbierato, M., Manev, H., & Giusti, P. (2008). Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum. Biochemical Pharmacology, 76(3), 391–403. doi:10.1016/j.bcp.2008.05.014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.